Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Last week, four researchers from Professor Leeson’s group within the Oxford Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, reached the final of the Young Investigator Awards at EuroPrevent 2015 in Lisbon.

Researchers from Cardiovascular Medicine reach the final of the Young Investigator Awards at Europrevent

EuroPrevent is the leading international conference on cardiovascular prevention within the European Society of Cardiology and this was a record number of investigators to have reached the finals from a single research group. Grace Yu’s work on the endothelial cell biology of offspring of hypertensive mothers was presented alongside work from (left to right in picture) Ross Upton on the application of novel echocardiographic computational shape analysis tools, Harry Boardman on the long term cardiovascular risk in mothers who suffer pregnancy complications and Wilby Williamson’s meta-analysis of physical activity for blood pressure control in young people.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with


Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.